Portrait of Molly S. Shoichet
Photo: Creator not stated by sourceSource · Source-linked editorial identification
Medical & Dental

Molly S. Shoichet

Injectable sustained-release hydrogel platform

CanadaEvidence: high confidenceChecked July 2026

Exact official-book portrait provenance only; do not extract or publish without rights review.

Who is Molly S. Shoichet?

Molly S. Shoichet is an inventor associated with Canada. Their documented work in medical & dental includes Injectable sustained-release hydrogel platform, the contribution at the center of this evidence-backed profile.

Shoichet co-founded AmacaThera around an injectable hydrogel platform that changes from liquid to gel at body temperature and localizes sustained drug delivery at a surgical site.

Known forInjectable sustained-release hydrogel platform
FieldMedical & Dental
Associated withCanada
Evidence reviewed2 sources
01

What did Molly S. Shoichet invent?

biomaterials and hydrogel-platform inventor

02

What did Molly S. Shoichet accomplish?

The platform gives a physical drug-delivery depot a two-week local release window; its AMT-143 product is under a global commercialization agreement for non-opioid post-surgical pain treatment.

03

What is known about Molly S. Shoichet today?

University of Toronto's November 2025 commercialization report identifies Shoichet as AmacaThera's co-founder and documents the Pacira agreement; the current engineering profile identifies her as University Professor and principal investigator.